Some GOP lawmakers in Congress have heralded the $50 billion rural program as a health care victory. But it’s still unclear which hospitals, clinics, and other providers would receive money and how ...

Cancer Therapy Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve ...

The allegation that almost 5 million nondisabled Medicaid recipients “simply choose not to work” is false, data suggest.

US inspectors have uncovered breakdowns in drugmaking at an Indian factory owned by Sun Pharma that produces generic medications for American consumers.

Health care providers can take steps to protect patients targeted by ICE, ensuring that patients retain their privacy and access to care.

Hospital officials are warning that changes in President Donald Trump’s budget and tax bill put them on an unsustainable track that could lead to closures or loss of services in rural communities.

Systematic mediastinal lymph node dissection (LND) is “unnecessary” for patients with ground glass opacity (GGO)-dominant invasive lung adenocarcinoma and low risk of nodal involvement, according to ...

The study results “highlight how even well-intentioned efforts to save patients’ time may face barriers,” the researchers wrote.

Prognostic Nutritional Index and systemic oxidative stress scores are associated with prognosis in patients with low-risk MDS, data suggest.

The data from this prospective cohort study confirm and expand previous retrospective case series that have found factors, including hematologic cancers, chemotherapy receipt, and lung cancer, as ...

While the accelerated approval pathway has enabled faster access to promising oncology drugs, meaningful improvements in survival or quality of life often remain unproven, even after full approval,” ...

The FDA has decided not to approve vusolimogene oderparepvec (RP1) in combination with nivolumab for advanced melanoma.